The SRC family kinase inhibitor NXP900 demonstrates potent antitumor activity in squamous cell carcinomas

  1. Dash, S.
  2. Hanson, S.
  3. King, B.
  4. Nyswaner, K.
  5. Foss, K.
  6. Tesi, N.
  7. Harvey, M.J.B.
  8. Navarro-Marchal, S.A.
  9. Woods, A.
  10. Poradosu, E.
  11. Unciti-Broceta, A.
  12. Carragher, N.O.
  13. Brognard, J.
Revista:
Journal of Biological Chemistry

ISSN: 1083-351X,  0021-9258

Any de publicació: 2024

Volum: 300

Número: 9

Tipus: Article

DOI: 10.1016/J.JBC.2024.107615 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus